AzurRX Biopharma Inc. (NASDAQ:AZRX) Stock Makes a Bullish After The Big News

August 19, 2021

AzurRX Biopharma Inc. (NASDAQ: AZRX) soared 32%, trading in heavy volume after the company released promising clinical study results for the MS1819 phase II combination therapy study in cystic fibrosis patients. Over 103 million shares exchanged hands compared to the average daily trading volume of $1.5 million shares. The company said that the combination of MS819 with the standard of care porcine-derived pancreatic enzyme replacement therapy demonstrated clinically significant improvement…

Read More >>